AML1/Eto Fusion Protein and Leukemogenesis

Frank, Richard C.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Clinical Investigator Award (CIA) (K08)
• Project #: 1K08CA070388-01
• Application #: 2114286
• Study Section: Cancer Research Manpower and Education Review Committee (CRME)
• Project Start: 1996-05-01
• Project End: 2001-04-30
• Budget Start: 1996-05-01
• Budget End: 1997-04-30
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Sloan-Kettering Institute for Cancer Research
• DUNS #: 064931884
• City: New York
• State: NY
• Country: United States
• Zip Code: 10065

Publications

Frank, R C; Sun, X; Berguido, F J et al. (1999) The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1. Oncogene 18:1701-10